About Us
Hermay Labs
Hermay Labs Corporation is a Canadian chemistry-based Contract Research Organization (CRO) dedicated to cutting-edge research and development. The company was founded in 2019 with a core focus on organic synthesis and medicinal chemistry. Since then, we have expanded our service areas to include computer-assisted drug discovery and development, cell-based assays, proteomics, drug delivery, and formulation. Our lab has completed multiple projects developing innovative technologies and products that improve human health and the environment. Currently, we are collaborating with our partners to establish a facility for kg scale API GMP manufacturing.
The company is based in scenic Edmonton, Alberta, Canada, and operates out of a 10,000-square-foot laboratory in the Edmonton Research Park. Our facility has the capability to synthesize complex chemical compounds in quantities ranging from micrograms to kilograms.
Our leadership team has over 30 years of synthetic, medicinal chemistry, and CRO experience with a strong record of successfully executing projects for industry and academic institutions. Hermay Labs is home to a team of skilled scientists with expertise in synthetic chemistry, medicinal chemistry, computational chemistry, and biochemistry. We are proud to have a healthy and supportive corporate culture whose core values include honesty, integrity, and innovation. Please feel free to contact us at info@hermaylabs.com
Key Scientific Leaders
John Yao, Ph.D., CEO
Dr. John Yao is an experienced scientist and entrepreneur. He has more than 30 years of experience in new drug development, chemical synthesis and operational management. Dr. Yao has founded and co-founded several companies ranging from contract research organization (CRO) to innovative drug discovery and development companies.
John Yao, Hermay Labs Corporation, a leading Contract Research Organizations (CRO) in Canada
Leonard I. Wiebe, DSc, Ph.D., Chief Scientific Officer
Dr. Wiebe is a seasoned medicinal chemist and an Adjunct Professor & Professor Emeritus in Department of Oncology, Faculty of Medicine & Dentistry at University of Alberta. Dr. Wiebe is the inventor of the widely used clinical PET imaging agent FAZA. Dr. Wiebe held research appointments at the University of Tübingen, the German Cancer Research Center, and Heidelberg University in Germany, and the Royal Prince Alfred Hospital and Sydney University in Australia. He has served as an expert consultant to numerous Universities and international agencies, including the Volkswagen Foundation, Cancer UK, the Helmholtz Foundation, and the Canadian Institutes for Health Research. Dr. Wiebe was the Alexander von Humboldt Foundation's first Ambassador Scientist for Canada (2007-2012) and the first permanent Director of Biomedicine and Health at ANSTO. He is a member of the Editorial Boards of several international scientific journals published in his fields of interest.
Dr. Len Wiebe, Hermay Labs Corporation
Dennis Hall, PhD, Scientific Advisor, synthetic chemistry
Dr. Hall is a Professor in the Department of Chemistry at the Faculty of Science, University of Alberta. He is an elected Fellow of the Royal Society of Canada and Canada Research Chair in Boron Chemistry for Catalysis and Drug Discovery. Dr. Hall was recognized with the award of the prestigious Killam Research Fellowship from the Canada Council for the Arts; one of only six awarded annually across the country in the fields of arts, science, and engineering.
Dr. Dennis Hall
Chang-Chun Ling, Ph.D., Scientific Advisor, Carbohydrate Chemistry, bioorganic chemistry
Dr. Ling is a Professor in the Department of Chemistry at the University of Calgary. He is an expert in carbohydrate chemistry and bioorganic chemistry. His research applies modern research techniques to understand carbohydrate-protein interactions involved in tumorigenesis, cancer metastasis, and infection, and to the design, synthesis, and immunological evaluation of microbial and tumor-associated mammalian carbohydrate antigens. Dr. Ling’s research team designed and synthesized inhibitors that selectively interfere with the crucial biosynthetic pathways that cancer cells rely on to survive, spread and proliferate. They have also designed molecules to raise antibodies with high immune specificity and immunoaffinity to prevent infectious disease.
Dr. Chang-Chun Ling
Services and Infrastructure
1. Full Time Equivalent (FTE) based medicinal chemistry and synthetic chemistry services
The company's leadership has over 30 years of synthetic chemistry, medicinal chemistry, and CRO leadership experience, which will be used to efficiently execute the medicinal and synthetic chemistry tasks:
i. Design and synthesis of analogs or focused libraries
ii. SAR studies and lead optimizations
iii. PROTAC drug discovery and development
iv. Antibody-drug conjugates (ADCs )
v. LNP and drug delivery system development
vi. Synthetic process development
vii. Cell-based assays
2. FFS based custom syntheses and other services
We provide fee-for-service-based services with quick delivery and reasonable prices:
i. Small molecule syntheses
ii. Heterocyclic molecule syntheses
iii. Carbohydrate syntheses
iv. Peptide syntheses
v. Lipid and LNP syntheses
vi Nucleic acid analogies and oligonucleotides
vii. HPLC purifications
viii. Polymer syntheses
ix. Reference compounds including deuterated compounds
x. Protein analysis and proteomics
xi Protein-ligand docking Molecular Modeling of Ligand-Protein Interactions
xii. proprietary compound design
xiii. Novel derivatives generating and analog generation to cover chemical space for IP Protection
xiv. Proprietary software-based prediction of toxicity, ADME, and PK
We Are Hiring
Working with us
Hermay Labs Corp is seeking knowledgeable, experienced, and motivated professionals capable of working effectively in a multidisciplinary team environment in Edmonton, Canada. We are looking for individuals from chemistry and other technical backgrounds to work collaboratively in our scientific laboratory to synthesize new chemicals, to create products and technologies that benefit the health of humans and the environment.
We offer the opportunity to work within a culture of highly motivated, talented individuals who are dedicated to the company's mission. Each job provides wide-ranging responsibilities due to our cross-functional organizational structure and leadership style, which ensures that everyone is engaged, committed and accountable.
Research Scientist / Senior Research Scientist – Chemistry
Candidates who have a strong synthetic organic chemistry background with MSc or PhD degree in Synthetic Chemistry are preferred. The Research Scientist / Senior Research Scientist will design and conduct chemical reactions and purification to synthesize complex organic compounds in our scientific laboratory.
The position will remain open until suitable candidates are found.
Please send your resume to info@hermay.ca